GlaxoSmithKline Pharmaceuticals Ltd is an Indian research-based pharmaceutical and healthcare company. Their product offering include vaccines, speciality medicines & general medicines. Its prescription medicines range across therapeutic areas such as anti-infectives, dermatology, gynaecology, diabetes, oncology, cardiovascular disease and respiratory diseases....
Glaxo breakout expectation Please follow strict risk reward and stop loss if you follow my levels... Charts for Educational purposes only Thanks, V Trade Point
Glaxo view triangle formation for today 14th Feb Buy chance above 1268 Sell below 1225 Follow strict risk rward and stop loss if u follow the level Charts for Educational purposes only Thanks, V Trade Point
Supply emerged around 1800 in Dec'21 Plan ahead, to Purchase Breakout above 1500 or, rejection indications near 1200 PB 8x PE 13x ROCE 33% Div 6%
GlaxoSmithKlein (GSK) just formed a Death Cross on the 1D time-frame, which is when the 1D MA50 (blue trend-line) crosses below the 1D MA200 (orange trend-line). This is technically a bearish pattern but last time it formed (March 24 2020) was exactly on the bottom of the COVID crash and the price recovered rapidly. That was of course in the aftermath of the...
GLAXO LONG Long term triangle formation. Now near breakout levels. With targets of 2100 in medium term. No recommendations, just view.
Bottom of the range looks a good place to buy GSK. Underperforming though and needs some impetus for share price growth.
GSK is showing a macro uptrend. Bearish divergence showing on the MACD and RSI. I have marked the previous divergence also, which preceded a sharp fall. We may be coming down to test the support line. The 2007-2009 dip is shown (38%)
Looking at Glaxo to see how it might perform in a market crash and recession. It has been making lower highs after a blow off top, and is now trending around the mean. Could be a reasonable place to sell here
GLAXO CMP 3180 Stop 2700 Target 3800 plus Weekly chart: Moved out of a brief consolidation zone with good volumes. Possibility of momentum taking the stock towards 3800 plus high.
Price has tested 1380 numerous times which can be seen with the long wicks testing and rejecting this level. There is RSI Divergence also which shows weakness in the price, sell a break of the counter trend and target the lows. Alternatively set an alert just above 1380 if the price breaks and closes above this level it would be a strong buy signal.
Price remove last 'peak' from left up moves and creating new wave up. I will wait on potential retracemnet arount to FIBO 61.8.
Happy New Year to all. New year has arrived with new opportunities. It is always good to start a new year with profitable note. Our short NIFTY and other selected stocks positions ( via puts of courses ) is well in green and now it looks like the test of solid support levels near 8200 / 8000 is inevitable in coming sessions. Many of the trades we have...
Preaching for patience by setting the examples ;) Roughly 6 months ago we published this piece on technical analysis of Glaxo SmithKline Pharmaceutical Stock. ( bombaybulls.com )It was mentioned clearly in that post that buying the stock near 3600 ( it was trading near that price in March, 2016 ) and hoping for it to reach 4000 might be a gamble ! Six months...